Dr. Nick Oberheiden focuses his litigation practice on white-collar criminal defense, government investigations, SEC & FCPA enforcement, and commercial litigation. He has defended clients in PPP Loan Fraud cases and COVID-19 investigations. Nick also directs internal corporate investigations and he leads defense teams in whistleblower actions, corporate defense cases, as well as cases involving national security and elected officials.
Clients from more than 45 U.S. states have hired Nick to seek effective protection against government investigations, grand jury proceedings, whistleblower cases, federal criminal cases, and regarding questions of corporate compliance. Known for his exceptional analytical skills and effectiveness, Nick routinely avoids criminal charges in federal investigations and, as one of few lawyers, Nick has obtained “Not Guilty” verdicts in federal criminal trials.
When pleading guilty to federal charges is simply not an option, Nick is available to identify promising litigation strategies and to prepare clients meticulously and diligently for trials. Nick has tried cases to verdict, and he has obtained several acquittals in federal white-collar criminal jury trials. Nick set his first federal precedent when he, in the early stage of private practice, convinced a federal judge to break with 70 years of established practice and redefined the subpoena authority of attorneys under Rule 45 Federal Rules of Civil Procedure. In that case alone, Nick quashed 14 federal subpoenas.
Nick has appeared in litigation proceedings throughout the United States and he has never once lost a motion for summary judgment, a motion on jurisdiction, or a whistleblower case.
Nick has written several widely published books, articles, and blogs and he has taught constitutional law and federal civil procedure on several continents. Nick’s Ph.D. thesis, a critical analysis of constitutional interpretation, was personally enriched by U.S. Supreme Court Justice Breyer, the Chief Justice of Brazil, and others.
More Legal and Business Bylines From Dr. Nick Oberheiden
- 7 FINRA/SEC Wells Notice Step-by-Step Response Strategies - (Posted On Thursday, July 28, 2022)
- 4 FAQs and 3 Defense Strategies for SEC Investigations - (Posted On Thursday, July 21, 2022)
- 3 Defense Strategies & 4 FAQs About Clinical Laboratory Investigation Cases - (Posted On Thursday, July 14, 2022)
- 4 Common Questions About Medical License Investigations and 3 Defense Strategies - (Posted On Thursday, July 07, 2022)
- How the Pharmacy Audit Appeals Process Works - (Posted On Thursday, June 30, 2022)
- 5 FAQs with FINRA Defense Attorney Nick Oberheiden - (Posted On Friday, June 24, 2022)
- How to Defend Against an Allegation of Healthcare Fraud in Detroit - (Posted On Monday, June 20, 2022)
- Medicare TPE Audits: What Providers Need to Know - (Posted On Thursday, June 09, 2022)
- 5 Keys to Successfully Defend Against Whistleblower Claims - (Posted On Thursday, June 02, 2022)
- Preparing for an On-the-Record (OTR) Interview: What Brokers Need to Know about FINRA Rule 8210 - (Posted On Thursday, May 26, 2022)
Dr. Nick Oberheiden of Oberheiden P.C. has been named a Go-To Thought Leader for his coverage of the US federal government’s various actions related to healthcare fraud. Dr. Oberheiden provided valuable insight into the federal government’s new enforcement effort into amniotic fluid injections, detailing how the treatment may be subject to investigation for fraud and scientific legitimacy by CMS and the US Department of Justice and saw considerable readership throughout the year.
Dr. Nick Oberheiden is a Go-To Thought Leader for 2021 for his coverage of FDA investigations. NLR readers turn to Dr. Oberheiden’s experience conducting internal investigations and leading defense teams in whistleblower cases. Of particular note are Dr. Oberheiden’s articles on what to expect when facing an investigation by a government agency like the FDA, outlining practical information and strategies readers can use.
The National Law Review named Dr. Nick Oberheiden of Oberheiden P.C as a Go-To Thought Leader for his ‘what to do’ advice related to federal target letters, FBI Subpoenas, Administrative Law Judge hearings and healthcare fraud investigations. Dr. Oberheiden’s experience conducting internal corporate investigations and leading defense teams in a variety of actions, including whistleblower and corporate defense cases really shows in his writing. Dr. Oberheiden also analyzes trends in federal enforcement including personal protection equipment fraud, pharmacy compliance and fraud issues, and the newly emerging area of Paycheck Protection Program Fraud.